Nova Scotia

Nova Scotia is rapidly emerging as a premier North American hub for life sciences innovation, bolstered by a collaborative ecosystem that integrates biotechnology, pharmaceuticals and medical device manufacturing.

At the heart of this growth is the Nova Scotia Health Innovation Hub, which accelerates the commercialization of cutting-edge healthcare solutions and digital health platforms by providing a direct pipeline to clinical settings.

The province is globally recognized for its clinical trial efficiency, boasting the highest number of active clinical trials per capita in Canada, supported by world-class institutions like Dalhousie University and the IWK Health Centre.

Nova Scotia's biotech sector excels in specialized areas such as genomics, vaccine development at the Canadian Centre for Vaccinology and pioneering marine biotechnology derived from its unique Atlantic coastline.

In the medtech space, the region is famous for breakthrough diagnostic tools and surgical robotics, including the development of world-first ultra-compact ultrasound devices.

The Life Sciences Research Institute (LSRI) serves as a central pillar for academic research, fostering partnerships between multidisciplinary scientists and global industry leaders to advance personalized medicine and neuroscience.

Furthermore, robust R&D tax incentives and a streamlined regulatory environment make Nova Scotia an attractive destination for life sciences investment and start-up incubation.

This vibrant cluster continues to transform patient outcomes through a unique synergy of precision medicine, bioinformatics and scalable healthcare innovation.